It's Never too Early to Think About Later
Ethicists Weigh in on Improving Quality of Early Stage Research
By Anette Breindl
Wednesday, March 9, 2011
How to improve the predictive value of preclinical drug discovery has preoccupied many a biotech executive. This week, advice on the topic has come from a somewhat unusual corner: philosophy.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.